ANI PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ani Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Ani Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$20.5M, a 214% decline year-over-year.
  • Ani Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $11.7M, a 72.2% decline year-over-year.
  • Ani Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was $47M.
  • Ani Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$35.3M, a 11.3% increase from 2021.
  • Ani Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$39.8M, a 148% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $11.7M -$20.5M -$38.5M -214% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $50.2M $5.17M -$7.23M -58.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $57.4M $20.3M +$10.4M +105% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $47M $6.73M +$4.91M +270% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $42.1M $17.9M +$22.9M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $19.1M $12.4M +$25.3M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$6.19M $9.9M +$29.1M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$35.3M $1.82M +$25.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$60.8M -$5M -$1.43M -40.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$59.4M -$12.9M +$2.64M +17% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$62M -$19.2M -$22.2M -730% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$39.8M -$23.7M -$24.1M -7267% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$15.7M -$3.56M -$6.36M -227% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$9.38M -$15.6M -$4.25M -37.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$5.13M $3.05M +$10.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$16M $331K +$5M Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$21M $2.8M -$4.53M -61.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$16.5M -$11.3M -$20.6M -222% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $4.11M -$7.84M -$12.2M -278% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $16.4M -$4.67M -$16.1M -141% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $32.5M $7.33M -$2.79M -27.5% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $35.3M $9.29M +$2.03M +27.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 $33.2M $4.4M -$2.14M -32.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 $35.4M $11.4M +$4.07M +55.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $31.3M $10.1M +$783K +8.39% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $30.5M $7.26M +$269K +3.85% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $30.2M $6.54M +$1.91M +41.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $28.3M $7.38M +$6.08M +468% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $22.2M $9.33M +$1.41M +17.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $20.8M $6.99M +$1.8M +34.7% Mar 31, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $19M $4.63M -$1.04M -18.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 $20.1M $1.3M -$4.97M -79.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 $25M $7.92M -$530K -6.27% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 $25.6M $5.19M -$3.22M -38.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 $28.8M $5.67M -$3.9M -40.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 $32.7M $6.27M -$4.5M -41.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 $37.2M $8.45M +$252K +3.07% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 $37M $8.41M +$10.9M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 $26.1M $9.57M +$6.07M +174% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 $20M $10.8M +$7.31M +211% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 $12.7M $8.2M +$7.39M +912% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-23
Q2 2014 $5.31M -$2.46M +$1.32M +34.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-23
Q1 2014 $3.99M $3.5M +$3.09M +767% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-23
Q4 2013 $898K $3.46M +$7.1M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 -$6.2M $810K +$1.02M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$7.21M -$3.78M -$4.36M -744% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$2.85M $403K +$7.33M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$10.2M -$3.64M +$4.71M +56.4% Oct 1, 2012 Dec 31, 2012 10-K 2013-02-28
Q3 2012 -$14.9M -$207K +$12.8M +98.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$27.7M $586K +$13.7M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$41.4M -$6.93M +$9.51M +57.8% Jan 1, 2012 Mar 31, 2012 10-K 2013-02-28
Q4 2011 -$50.9M -$8.34M +$4.83M +36.7% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 -$55.7M -$13M -$1.79M -15.9% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-28
Q2 2011 -$53.9M -$13.1M -$2.82M -27.6% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-28
Q1 2011 -$51.1M -$16.4M -$7.48M -83.5% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-28
Q4 2010 -$43.6M -$13.2M Oct 1, 2010 Dec 31, 2010 8-K 2013-01-28
Q3 2010 -$11.2M Jul 1, 2010 Sep 30, 2010 8-K 2013-01-28
Q2 2010 -$10.2M Apr 1, 2010 Jun 30, 2010 8-K 2013-01-28
Q1 2010 -$8.96M Jan 1, 2010 Mar 31, 2010 8-K 2013-01-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.